Insider Transactions in Q4 2021 at Incyte Corp (INCY)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+4.13%
|
$25,039
$73.4 P/Share
|
|
Dec 31
2021
|
Wendy L Dixon Director |
BUY
Grant, award, or other acquisition
|
Direct |
260
+1.46%
|
$18,980
$73.4 P/Share
|
|
Dec 31
2021
|
Jacqualyn A Fouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
289
+3.39%
|
$21,097
$73.4 P/Share
|
|
Dec 31
2021
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
253
+4.53%
|
$18,469
$73.4 P/Share
|
|
Dec 31
2021
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
838
+0.01%
|
-
|
|
Dec 23
2021
|
Wendy L Dixon Director |
SELL
Open market or private sale
|
Direct |
20,000
-53.68%
|
$440,000
$22.05 P/Share
|
|
Dec 23
2021
|
Wendy L Dixon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+34.93%
|
$1,460,000
$73.25 P/Share
|
|
Dec 17
2021
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
1,075,872
+1.71%
|
$77,462,784
$72.84 P/Share
|
|
Dec 16
2021
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
169,315
+0.28%
|
$12,021,365
$71.98 P/Share
|
|
Dec 15
2021
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
350,332
+0.2%
|
$24,172,908
$69.87 P/Share
|
|
Dec 10
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
533
-1.57%
|
$34,645
$65.4 P/Share
|
|
Nov 19
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+3.83%
|
-
|
|
Nov 19
2021
|
Barry P Flannelly EVP & General Manager US |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+2.27%
|
-
|
|
Nov 19
2021
|
Herve Hoppenot Chairman / CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,506
+2.18%
|
-
|
|
Nov 19
2021
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+4.35%
|
-
|
|
Nov 19
2021
|
Maria E Pasquale EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+3.35%
|
-
|
|
Nov 19
2021
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+3.06%
|
-
|
|
Nov 19
2021
|
Steven H Stein EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+1.28%
|
-
|
|
Nov 19
2021
|
Paula J Swain EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+2.09%
|
-
|
|
Oct 01
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
389
-1.23%
|
$26,452
$68.67 P/Share
|